136 related articles for article (PubMed ID: 19439488)
1. Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin.
Gulati A; Boudinot FD; Gerk PM
Drug Metab Dispos; 2009 Aug; 37(8):1572-5. PubMed ID: 19439488
[TBL] [Abstract][Full Text] [Related]
2. Lopinavir protein binding in HIV-1-infected pregnant women.
Aweeka FT; Stek A; Best BM; Hu C; Holland D; Hermes A; Burchett SK; Read J; Mirochnick M; Capparelli EV;
HIV Med; 2010 Apr; 11(4):232-8. PubMed ID: 20002783
[TBL] [Abstract][Full Text] [Related]
3. Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.
Fayet-Mello A; Buclin T; Guignard N; Cruchon S; Cavassini M; Grawe C; Gremlich E; Popp KA; Schmid F; Eap CB; Telenti A; Biollaz J; Decosterd LA; Martinez de Tejada B; ;
Antivir Ther; 2013; 18(2):171-82. PubMed ID: 22914504
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
5. Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure.
Ofotokun I; Lennox JL; Eaton ME; Ritchie JC; Easley KA; Masalovich SE; Long MC; Acosta EP
J Clin Pharmacol; 2011 Nov; 51(11):1539-48. PubMed ID: 21209245
[TBL] [Abstract][Full Text] [Related]
6. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
[TBL] [Abstract][Full Text] [Related]
7. Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
Colombo S; Buclin T; Décosterd LA; Telenti A; Furrer H; Lee BL; Biollaz J; Eap CB;
Clin Pharmacol Ther; 2006 Oct; 80(4):307-18. PubMed ID: 17015049
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
9. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
Yadav M; Rao R; Kurani H; Singhal P; Goswami S; Shrivastav PS
J Pharm Biomed Anal; 2009 May; 49(4):1115-22. PubMed ID: 19282124
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.
Moltó J; Barbanoj MJ; Miranda C; Blanco A; Santos JR; Negredo E; Costa J; Domingo P; Clotet B; Valle M
Clin Pharmacokinet; 2008; 47(10):681-92. PubMed ID: 18783298
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of indinavir, ritonavir and lopinavir (ABT 378) in human plasma by high-performance liquid chromatography.
Ray J; Pang E; Carey D
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):225-30. PubMed ID: 12113989
[TBL] [Abstract][Full Text] [Related]
12. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.
Ribeiro RMP; Moreira FL; Moisés ECD; Cavalli RC; Quintana SM; Lanchote VL; Duarte G
Br J Clin Pharmacol; 2018 Oct; 84(10):2415-2421. PubMed ID: 29959798
[TBL] [Abstract][Full Text] [Related]
13. CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects.
Estrela RC; Santoro AB; Barroso PF; Tuyama M; Suarez-Kurtz G
Clin Pharmacol Ther; 2008 Aug; 84(2):205-7. PubMed ID: 18288082
[TBL] [Abstract][Full Text] [Related]
14. Lopinavir/ritonavir absorption in a gastrectomized patient.
Boffito M; Lucchini A; Maiello A; Dal Conte I; Hoggard PG; Back DJ; Di Perri G
AIDS; 2003 Jan; 17(1):136-7. PubMed ID: 12478084
[No Abstract] [Full Text] [Related]
15. Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model.
Gavard L; Gil S; Peytavin G; Ceccaldi PF; Ferreira C; Farinotti R; Mandelbrot L
Am J Obstet Gynecol; 2006 Jul; 195(1):296-301. PubMed ID: 16678781
[TBL] [Abstract][Full Text] [Related]
16. Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine.
Manavi K; McDonald A; Al-Sharqui A
AIDS; 2007 Mar; 21(5):643-5. PubMed ID: 17314527
[TBL] [Abstract][Full Text] [Related]
17. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Zini R; Morin D; Salvadori C; Tillement JP
Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
[TBL] [Abstract][Full Text] [Related]
18. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
[TBL] [Abstract][Full Text] [Related]
19. Reduced lopinavir exposure during pregnancy.
Stek AM; Mirochnick M; Capparelli E; Best BM; Hu C; Burchett SK; Elgie C; Holland DT; Smith E; Tuomala R; Cotter A; Read JS
AIDS; 2006 Oct; 20(15):1931-9. PubMed ID: 16988514
[TBL] [Abstract][Full Text] [Related]
20. The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men.
Kohlrausch FB; de Cássia Estrela R; Barroso PF; Suarez-Kurtz G
Br J Clin Pharmacol; 2010 Jan; 69(1):95-8. PubMed ID: 20078617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
